ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale (Q36226980)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

author name string

Lunenfeld B

1

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Saad F

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Hoesl CE

3

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

59-74

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Age, Disease, and Changing Sex Hormone Levels in Middle-Aged Men: Results of the Massachusetts Male Aging Study*

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgen deficiency and the aging male: new urologic perspectives

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Construction and field validation of a self-administered screener for testosterone deficiency (hypogonadism) in ageing men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgen therapy in the aging male

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

The relationship between pituitary-gonadal function and sexual behavior in healthy aging men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Sexual function in men older than 50 years of age: results from the health professionals follow-up study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Secondary hypogonadism in older men: its relation to impotence

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Laboratory evaluations of erectile dysfunction: an evidence based approach

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Organic, relational and psychological factors in erectile dysfunction in men with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of Medical or Surgical Castration on Erectile Function in an Animal Model

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

The relationship of serum testosterone to erectile function in normal aging men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Pilot study of the transdermal application of testosterone gel to the penile skin for the treatment of hypogonadotropic men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Vascular risk factors and erectile dysfunction

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Relation between psychosocial risk factors and incident erectile dysfunction: prospective results from the Massachusetts Male Aging Study.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS).

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone and behavior

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Longitudinal assessment of serum free testosterone concentration predicts memory performance and cognitive status in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Sex hormones and cognitive function in older men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Activational effects of testosterone on cognitive function in men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effect of oral testosterone undecanoate on visuospatial cognition, mood and quality of life in elderly men with low-normal gonadal status

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone influences spatial cognition in older men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effect of testosterone deprivation on the cognitive performance of a patient with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone reduces neuronal secretion of Alzheimer's beta-amyloid peptides

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone stimulates rapid secretory amyloid precursor protein release from rat hypothalamic cells via the activation of the mitogen-activated protein kinase pathway

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Depression in aging men: the role of testosterone

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Sleep EEG and nocturnal secretion of testosterone and cortisol in patients with major endogenous depression during acute phase and after remission

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Low testosterone levels in elderly men with dysthymic disorder

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Predictors of skeletal muscle mass in elderly men and women.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Sex steroid hormones, upper body obesity, and insulin resistance.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Aging and tissue androgens

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Sexual hormones utilize complex mechanisms to modulate sebocyte differentiation

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Acne: effect of hormones on pathogenesis and management

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgens and alopecia

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Hormonal profile of men with premature balding.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Sebocytes are the key regulators of androgen homeostasis in human skin

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Human skin: an independent peripheral endocrine organ

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Risk factors for male osteoporosis

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Does hypogonadism contribute to the occurrence of a minimal trauma hip fracture in elderly men?

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Determinants of bone density in healthy older men with low testosterone levels

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Bone mineral density outcomes following long-term treatment with subcutaneous testosterone pellet implants in male hypogonadism

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of long-term testosterone substitutive therapy on bone mineral content in men with hypergonadotrophic hypogonadism

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgen replacement in aging men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Andropause (or symptomatic late-onset hypogonadism): facts, fiction and controversies

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

A critical evaluation of simple methods for the estimation of free testosterone in serum

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Hyperprolactinemia in men: clinical and biochemical features and response to treatment

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone therapy--what, when and to whom?

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgen replacement therapy: present and future

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

A new oral testosterone undecanoate formulation

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Uses of DHEA in aging and other disease states

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Hormone substitution in male hypogonadism

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Human chorionic gonadotropin (hCG), the hormone of life and death: a review

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Recombinant human chorionic gonadotropin but not dihydrotestosterone alone stimulates osteoblastic collagen synthesis in older men with partial age-related androgen deficiency

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

A double-blind, placebo-controlled, randomized clinical trial of recombinant human chorionic gonadotropin on muscle strength and physical function and activity in older men with partial age-related androgen deficiency

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomized, placebo-controlled clinical trial of recombinant human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Risks of testosterone-replacement therapy and recommendations for monitoring

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

STUDIES ON PROSTATIC CANCER

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgen deprivation therapy for prostate cancer: current status and future prospects

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Prostate cancer after exogenous testosterone treatment for impotence

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone replacement therapy after primary treatment for prostate cancer

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Androgens and Erythropoiesis

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Risks versus benefits of testosterone therapy in elderly men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of testosterone on mood, aggression, and sexual behavior in young men: a double-blind, placebo-controlled, cross-over study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men.

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Effects of Castration and Androgen Replacement on Erectile Function in a Rabbit Model1

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Leg Muscle Mass and Composition in Relation to Lower Extremity Performance in Men and Women Aged 70 to 79: The Health, Aging and Body Composition Study

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly

1 reference

https://api.crossref.org/works/10.1080%2F13685530500163416

21 January 2018

Identifiers

10.1080/13685530500163416

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36226980&oldid=1868168603"